Drug Trial Radar · NCT00144768
A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients
Last checked: Nov 20, 2026Latest source record: May 5, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Planned (sponsor's estimate)
Start
Jul 2004
Primary completion
May 2007
Study completion May 2007
Sponsor
- Lead sponsor
- Genzyme, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- Collaborators
- BioMarin/Genzyme LLC
- First posted
- Sep 5, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether the development of antibodies to laronidase in patients with MPS I receiving Aldurazyme® impairs the clearance of GAG substrate.
Conditions
- Mucopolysaccharidosis I
- Hurler's Syndrome
- Hurler-Scheie Syndrome
- Scheie's Syndrome
Interventions
laronidaseDrug
dose of 0.58mg/kg body weight IV every week
Primary outcomes
What the sponsor says the trial is designed to measure.
- Urinary GAG (glycosaminoglycans)Time frame: Up to 4 years
- Immunogenicity TestingTime frame: Up to 4 years
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Childrens Hospital Los Angeles
Los Angles, California
Connecticut Children's Medical Center
Hartford, Connecticut
Children's Hospital of Wisconsin
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.